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A convenient synthetic route towards 1-hydroxymethylene-1,1-
bis(H-phosphinates)† 
Jade Dussart, Nicolas Guedeney, Julia Deschamp, Maelle Monteil, Olivier Gager, Thibaut Legigan, 
Evelyne Migianu-Griffoni* and Marc Lecouvey* 
A practical general route to 1-hydroxymethylene-1,1-bis(H-phosphinates) has been developed. Diverse alkyl 
or (hetero)aryl bisphosphinates were rapidly obtained in satisfying to excellent yields from corresponding acid 
chlorides and in situ generated bis(trimethylsilyl)phosphonite. This work is complementary to previous 
approaches. A generalisable procedure was optimised allowing the description of numerous compounds. To 
check the literature data, a pka value study was also performed.
Introduction 
Tetracoordinate pentavalent phosphorus compounds are 
broadly represented as pharmacophores in various classes of 
therapeutic agents.1-3 Among phosphorylated molecules used 
in clinic, 1-hydroxymethylene-1,1-bisphosphonates (HMBPs) 
occupy a prominent place. Because of their affinity for the 
calcium ions, they are currently the most widely used treatment 
of bone pathologies.4 They are used as inhibitors of bone 
resorption, in particular osteoporosis, solid tumor bone 
metastases and myeloma bone disease. Moreover, these 
compounds have interesting antitumor effects on soft tissue 
primary tumor models (breast, prostate…) as well in vitro as in 
vivo. HMBPs exhibit two distinct action mechanisms depending 
on their side chain nature. The first leads to the cytotoxic ATP 
derivative formation at high concentration.4,5 In the second 
mechanism, farnesylpyrophosphate synthase (FPPS), a key 
enzyme in the mevalonate pathway, is inhibited at low 
concentration (especially true for HMBPs having a nitrogen on 
the side chain).6-8 More recently, a new allosteric pocket on 
FPPS has been discovered, opening a novel pharmacological 
field for HMBPs and derivatives as SAR studies have shown that 
farnesylpyrophosphate itself is inhibitor.9 However, while they 
have demonstrated great promise, the bisphosphonate main 
drawback is their weak bioavailability.10 HMBPs carry two or 
three negative charges at physiological pH making them very 
polar, thus limiting their cell uptake. To improve their 
pharmacological properties, lipophilic prodrug strategies in 
which HMBP negative charges were partially masked have been 
evaluated.11-16 In this context, our laboratory has proposed 
several methodologies to synthesise regioselectively various 
HMBP cleavable mono-, di- and triesters.17,18 Another few 
described strategy is the replacement of the phosphonic group 
by a phosphinic moiety. This function presents some 
advantages such as lower acidity and ionicity at physiological pH 
and lower affinity for bone to targeting soft tissues. In contrast 
to bisphosphonates, limited number of studies have focused on 
the synthesis and chemical properties of bisphosphinates.19-24 
David et al. described only 3 examples of 1-hydroxymethylene-
1,1-bis(H-phosphinic acids) to study their bone affinity and one 
aminoalkyl-1-hydroxymethylene-1,1-bis(H-phosphinic acid) in 
order to assess their stability, acid/base and coordination 
properties.21 They proposed a procedure using a large excess of 
bis(trimethylsilyl)phosphonite (8 equivalents) to obtain total 
conversion of acid chloride (Scheme 1). After ethanolysis, 
expected compounds were obtained with a large quantity of 
phosphorous acid. Difficulties are often observed to separate 
phosphorous acid from 1-hydroxymethylene-1,1-bis(H-
phosphinic acids) requiring tedious purifications and thus 
decreasing the yields. 
 Here, we take advantage of our former work on 
bisphosphonates in order to develop a convenient methodology 
to access to 1-hydroxymethylene-1,1-bis(H-phosphinic acid) (H-
HMBPi) derivatives. 
 
Scheme 1 Syntheses of H-HMBPi scaffolds. 
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Scheme 2 Postulated pathway to H-HMBPi 6 synthesis. 
 The synthetic pathway started from substituted acid 
chlorides and readily available hypophosphorous acid in 
presence of N,O-bis(trimethylsilyl)acetamide (BSA) as silylating 
agent. This procedure provides easily purified H-HMBPi 
disodium salts in higher yields, shorter reaction times  and a 
wide range of aliphatic and (hetero)aromatic substituents than 
previously reported19-21,23,24 (Scheme 1). 
Results and discussion 
This present work builds on the following postulated pathway 
inspiring by our previous works on 1-hydroxymethylene-1,1-
bisphosphonate (HMBP) syntheses18 (Scheme 2). The access to 
H-HMBPi scaffold relies on the existing equilibrium between 
hypophosphorous acid 1 and its H-phosphonite form 1-(PIII) 
that could be trapped in presence of a silylating agent to afford 
the well-known bis(trimethylsilyl)phosphonite (BTSP) 2. The 
first addition of 2 on an acid chloride could generate a silylated 
-ketophosphinate 4 which could subsequently react with a 
second equivalent of BTSP 2. Then, the resulting silylated 
H-bisphosphinate 5 could undergo a methanolysis step 
following by a pH adjustment to 7, at which the H-HMBPi 
disodium salt 6 should be expected. 
 Our first experiments were performed with 
hypophosphorous acid 1 and acetyl chloride 3a in presence of 
N,O-bis(trimethylsilyl)acetamide (BSA) as a silylating agent 
under argon atmosphere (Table 1). Indicated concentrations of 
reagents corresponded to solvent volumes required for a 
homogeneous reaction mixture stirring at the considered 
temperature. Initially, the silylated phosphonite 2 which was in 
situ generated by adding two equivalents of BSA to H3PO2 was 
added portionwise to an acetyl chloride 3a solution at -70 °C 
(entry 1; method A). We were pleased to observe the formation 
of the expected H-HMBPi 6a after 1.5 hours in an average yield 
of 47% after purification. The reaction progress was routinely 
monitored by 31P{1H} and 31P NMR (for more details, see 
Scheme 1 in ESI). First of all, we expectedly observed the fast 
appearance of the silylphosphonite 2 (141.4 ppm) starting from 
1 (12.8 ppm). When the acetyl chloride 3a solution underwent 
the attack of 2, its signal disappeared in favor of several emer-
Table 1 Reaction between acetyl chloride 3a and hypophosphorous acid 1 in 
presence of N,O-bis(trimethylsilyl)acetamide (BSA).a 
 
Entry Methodb Temp (°C) 
[3a]  
(M) 
[2]  
(M) 
Time Yieldf (%) 
1 A -70 2.25c 10c 1.5 hd 47 
2 A 0 5c 10c 18 h - 
3 B -70 5c 1c 25 mine 54 
4 B 0 5c 1c 10 mine 65 
5 B 0 5 10 20 mine 55 
6 B 0 2.25 10 20 mine 57 
7 B 0 5 5 20 mine 91 
8 B -25 5 5 20 mine 88 
aReaction conditions: 1 (10 mmol), BSA (20 mmol), 3a (5 mmol), THF, Ar, 0 °C. 
bFor details see Experimental section. cConcentrations were adjusted 
depending on addition method and temperature in order to obtain sufficient 
solution volumes to allow the reaction occurring. dTime of reaction completion 
monitored by 31P{1H} and 31P NMR; the indicated time includes the time of 
addition. eTime of reaction completion monitored by 31P{1H} and 31P NMR; the 
indicated time corresponds to the addition time. fIsolated yield of H-HMBPi 6a.  
ging signals in P(III)/P(V) species region (142-144 and 20-25 
ppm). A sole signal corresponding to the bisphosphinic acid was 
observed after methanolysis of the reaction mixture following 
by a pH adjustment to 7. Unfortunately, we never were able to 
identify the signal corresponding to the -ketophosphinate 
intermediate 4 even after adding only few drops of BTSP 2 
solution at -70 °C. This intermediate 4 should be highly reactive 
and thus, instantly react to give the corresponding silylated 
bisphosphinate 5.25 It was also noted that small amounts of 
hypophosphorous acid (7%) and phosphorous acid (11%) were 
detected in the reaction mixture probably due to BTSP 
disproportionation (see Scheme 1 in ESI). Surprisingly, when the 
reaction was conducted at 0 °C, no reaction occurred. Only 
hypophosphorous acid, phosphorous acid and acetic acid were 
recovered after methanolysis (entries 2 vs 1). The reagent 
addition order was then studied (entries 3 vs 1-2; method B). 
The acetyl chloride solution was this time added onto BTSP 2 at 
-70 °C, the temperature at which H-HMBPi 6a was formed 
during the first assay. In this case, the reaction was already 
completed at the end of the acetyl chloride addition (25 min), 
and H-HMBPi disodium salt 6a was isolated in a better yield of 
54%. We were also delighted to find that the same reaction 
could be succeeded in only 10 min at 0 °C in 65% yield (entries 
4 vs 3). Thereafter, we investigated the influence of the reagent 
concentrations in order to enhance the reaction process 
(entries 5-7). 
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Scheme 3  Scope of the reaction between hypophosphorous acid 1 and various acid chlorides 3a-x in presence of N,O-bis(trimethylsilyl)acetamide (BSA). 
Higher concentration of the silylated phosphonite 2 allowed to 
perform the reaction in 20 min at 0 °C in a lower yield (55%, 
entries 5 vs 4) while the acetyl chloride dilution did not 
influence the outcome of the reaction (entries 6 vs 5). Finally, 
we found that the same reagent concentrations (5M) were the 
best compromise in terms of short reaction time and improved 
yields (entries 7 vs 4-6). A last assay was carried out at -25 °C in 
the same concentration and time conditions as entry 7 to check 
the temperature influence on the reaction efficiency (entry 8). 
The obtained 88% yield encouraged us to select entry 7 
parameters as the best and convenient conditions of addition 
and temperature. 
 We have simultaneously studied the same parameter 
variations on presence of the aromatic acid chloride 3b instead 
of acetyl chloride 3a to ensure the procedure viability (see Table 
1 in ESI). We were pleased to observe the same improvement 
for this aromatic substrate suggesting that this methodology is 
generalisable as well as aliphatic as aromatic acid chlorides. 
Under the previous optimised conditions, the expected 
bisphosphinate disodium salt 6b was obtained in a very 
satisfying yield of 87% in 20 min. 
 We consequently pursued our investigation by studying the 
scope of the reaction on various acid chlorides (Scheme 3). The 
reaction was carried out between aliphatic acid chlorides 3c-f 
and BTSP 2. In all cases, the corresponding H-bisphosphinates 
6c-f were isolated in excellent yields of 86 to 95%. The reaction 
rate was very fast as all the reactions were complete at the end 
of alkyl acid chloride additions. It was noted the reaction is very 
effective even in the presence of bulkier acid chloride 3c (R1 = 
iPr) as the corresponding H-HMBPi 6c was obtained in 95% 
yield. Moreover, it should be noticed that enol formation was 
never observed after attack of BTSP 2 on phenyl acetyl chloride 
3f as reported by Burgada in bisphosphonate series.26 Then, the 
screening of various substituted aromatic acid chlorides 3g-u 
was performed under optimised conditions. Reactions were 
generally successful in moderate to excellent yields (37-95%). 
The presence of alkyl or methoxy groups at the para position of 
benzoyl chloride provided the expected H-HMBPi 6g-i in very 
good yields (88-95%). When the reaction was conducted in 
presence of halogenated substituents (4-fluoro, 4-bromo and 4-
trifluoromethoxy), the bisphosphinates 6j-l were also isolated in 
satisfying to good yields (67-85%). However, electro-
withdrawing trifluoromethyl group gave the corresponding 
para-substituted bisphosphinate 6m in the lowest yield of 37%. 
 The introduction of electro-donating and electro-
withdrawing substituents at meta- and ortho- positions of 
benzoyl chloride were also considered (compounds 6n-u). As a 
general trend, the presence of a methyl- or a methoxy- group at 
meta- or ortho- position led to similar behaviours. Indeed, these 
expected H-HMBPi were obtained in very good yields of 80% 
and 81% for 6n and 6o while it decreased for 6r and 6s (67% and 
77%) probably due to steric hindrance. Concerning the halogen 
substituted compounds, the yield decreased from 85% for the 
para- position (6j) to 70% and 67% for meta- and ortho- fluoro-
derivatives respectively (6p and 6t). In the same way, the yield 
declined drastically with the bromo substitution from 67% (6k, 
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para- compound) to 62% and 46% (6q, meta- and 6u, ortho- 
derivatives).  
 Finally, the reaction was extended to 1-naphtyl- and 
heteroaromatic (2-furyl and 2-thiophenyl) substituted acid 
chlorides 3v-x, and we were pleased to isolate the 
corresponding H-HMBPi 6v-x in moderate to rather good yields 
(55-70%). 
 For some aromatic H-HMBPi analogues (6k-m, 6p-r, 6t-v), 
we also observed the formation of a side product in various 
amounts (beyond 10%). It was noted that this quantity could be 
negligible for the other aromatic substrates. Indeed, the 31P{1H} 
NMR monitoring of the reaction showed the presence of the 
expected silylated H-HMBPi 5 signal and another silylated 
species in the P(V) spectral area as two doublets. After 
methanolysis and pH adjustment to 7, 31P{1H} NMR analysis 
presented similar two doublets in the same proportion around 
23 and 6 ppm (P(V) region again) indicating two different non-
equivalent phosphorus atoms. According to NMR spectra, this 
compound represented 10 to 40% proportion (31P NMR) of 
crude products mixed with the corresponding H-HMBPi 6, 
phosphorous acid and acetamide. However, H-HMBPi 6 could 
be easily separated from crude product thanks to washes with 
ethanol then methanol. The side product could not be isolated 
in pure form nevertheless we were able to distinguish its 
signals. 1H and 13C 1D and 2D NMR and mass spectrometry 
experiments allowed identification of a phosphino-
phosphonate isomer as the by-product (see Figures 1a-f in ESI). 
Indeed, 1H NMR spectrum showed a new signal compared to H-
HMBPi 6 about 5 ppm assigned to a proton in benzylic position. 
The presence of this group was confirmed by 13C NMR spectrum 
with a doublet of doublets around 74 ppm (instead of a triplet 
for H-HMBPi 6) and a one-bond correlation in HMQC NMR of 
these two chemical signals. It should be noted that this by-
product was never formed in aliphatic series. 
 In order to understand how phosphino-phosphonate isomer 
was formed, 31P{1H} NMR studies were set up. As it appeared 
before methanolysis, the first investigation was to determine if 
this isomer resulted from a rearrangement of the silylated 
intermediate 5 or from a reaction starting with the silylated -
ketophosphinate 4. Benzoyl acid chloride 3b (R = Ph) which gave 
only 6% amount of the silylated phosphino-phosphonate 
isomer (about 14 and 31 ppm) in optimised conditions (method 
B) was selected for this study (Figure 1a). The first experiment 
was carried out adding benzoyl acid chloride 3b in one portion 
onto BTSP 2 (method B) at 50 °C in the aim of promoting rapidly 
the silylated H-HMBPi 5 formation. Indeed, under method B 
conditions, the high BTSP 2 concentration would disfavour the 
silylated -ketophosphinate 4 accumulation. After 5 minutes, 
the 31P{1H} NMR analysis indicated the isomer presence in 
comparable amount (9%) as reference spectrum (a). 
 
 
 
Figure 1 31P NMR monitoring of phosphino-phosphonate isomer formation (a) by method B at 0 °C; (b) by method B at 50 then 70 °C; (c) by method A at 70 °C. 
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This proportion did not change over time or increasing 
temperature (Figure 1b). This result suggested that bis-silylated 
phosphino-phosphonate was not formed from silylated H-
bisphosphinate 5b but might result from a rearrangement 
during the reaction or from another reaction starting from 
silylated -ketophosphinate 4. Besides, bis-silylated phosphino-
phosphonate isomer seemed to be rapidly formed at the 
beginning of the reaction. In the second experiment, BTSP 2 was 
added dropwise on benzoyl chloride 3b (method A) at 70 °C in 
order to promote more the formation of silylated -
ketophosphinate 4 than in method B. In these conditions, the 
ratio silylated H-bisphosphinate/ silylated isomer was totally 
different after only 5 minutes from 90/10 in the first assay 
(Figure 1b, T = 70 °C) to 37/63 (Figure 1c). These ratios might 
suggest the bis-silylated phosphino-phosphonate was more 
formed from silylated -ketophosphinate 4. 
 Based on those structure/formation elucidation and 
previous observation on BP tetraester rearrangement,27 we 
envisioned a first plausible mechanistic pathway of phosphino-
phosphonate isomer 11 formation (Scheme 4, pathway A). As 
earlier reported in Scheme 2, the silylated -ketophosphinate 4 
could be firstly generated from the reaction between BTSP 2 
and aryl acid chloride 3. A nucleophilic addition of the second 
equivalent of BTSP 2 on the carbon atom of 4 would lead to 
intermediate 7. Whereas phosphonium transilylation led to the 
silylated H-HMBPi 5 (H-HMBPi pathway), we proposed here the 
formation of the 1,2-oxaphosphirane 8, because of a low steric 
hindrance of this phosphonium. The unfavourable 
pentacoordinate phosphorus and three-membered ring could 
generate the intermediate 9. However, we had also considered 
another mechanism from silylated -ketophosphinate 4 
inspired by reported reactions between aromatic dialkyl -
ketophosphonates and trialkyl phosphites.28,29 In this way, the 
addition of the second equivalent of BTSP 2 directly on the 
carbonyl oxygen atom could furnish the same proposed 
carbanion 9. In both pathways A and B, the formation of this 
negative charge in benzylic position may explain why 
phosphino-phosphonate isomer was exclusively obtained in 
aromatic series. Indeed, this carbanion could be stabilised 
especially with electro-withdrawing substituents, as observed. 
The phosphonium 9 could then move towards bis-silylated 
phosphino-phosphonate 10 giving the phosphino-phosphonate 
isomer 11 after methanolysis and pH adjustment to 7. 
 To complete our study, we investigated pka values of 
synthesised H-HMBPi derivatives, especially as only few 
contradictory data are available in the literature.19-20 
Surprisingly, Kaboudin et al. reported two unexpected pka 
values between 8.1 and 8.7 and 9.3 and 11.9 respectively for 
aliphatic and aromatic HMBPi.19 These surprising results 
encouraged us to determine pka values of some synthesised 
H-HMBPi derivatives 6. Molecules 6c (R1 = iPr, branched alkyl 
chain) and 6g (R1 = p-MePh, substituted aryl) were chosen. 
Titrations by an aqueous solution of NaOH (0.04M) were 
performed with a pure product in its acidic form (adjustment pH 
step to 7 was omitted here). Purifications and titrations had to 
be carried out rapidly due to the low stability of the compounds 
under acidic conditions. pH data exploitation indicated two pka 
values are 1.89 and 1.97 for H-HMBPi 6c and 1.81 and 1.86 for 
H-HMBPi 6g (for more details, see Figures 2a and 2b in ESI). 
These results are in contradiction with Kaboudin’s values but in 
accordance with David’s study.20 Indeed, reported pka values for 
bis(methylphosphinic acid) are 1.95 and 3.63 corresponding to 
the two phosphinic acids and are in agreement with our 
experimental values for bis(H-phosphinic acid). 
 An additional study of H-HMBPi 6g pH evolution depending 
on chemical shift in 31P{1H} NMR was leaded (see Figure 2c in 
ESI). Results were in agreement with pka values around 2. 
Moreover, this study showed the H-HMBPi 6 existed exclusively 
on disodium salt form at pH = 7. 
 
 
 
 
Scheme 4 Proposed mechanistic pathways of phosphino-phosphonate isomer 11 formation. 
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Scheme 5  Synthesis of alendronate H-HMBPi analogue 12. 
 Afterwards, we aimed at applying our optimised 
methodology to the synthesis of biologically relevant 
compounds. We focused on the synthesis of one H-HMBPi 
which is alendronate bisphosphinate analogue 12 (Scheme 5). 
Our one-pot procedure was performed with 4-azidobutanoyl 
chloride30 3y which underwent the attack of BTSP 2 to afford 
the corresponding H-HMBPi 6y in 80% yield after methanolysis 
and basic treatment. After treatment of bisphosphinate 6y with 
Dowex H+ resin, the catalytic hydrogenation of the azido 
function was carried out with palladium on carbon. After pH 
adjustment and simple washes, the disodium salt alendronate 
bisphosphinate analogue 12 was obtained in better yield (80%) 
than previously reported.20 
Conclusions 
To conclude, we have developed an efficient userfriendly 
methodology allowing the access to various 
1-hydroxymethylene-1,1-bis(H-phosphinates) in short reaction 
times, easy purification steps and rather good to excellent 
yields. Our general optimised procedure can be successfully 
applied as well as alkyl than (hetero)aromatic acid chlorides and 
allowed the preparation of biologically relevant 
organophosphorus compounds such as the alendronate 
bisphosphinate analogue. 
Synthesis and biological evaluation of other bisphosphinates of 
interest will be reported soon.  
Experimental section 
General information. Chemicals were purchased from common 
commercial suppliers (Sigma-Aldrich, Alfa Aesar, Acros Organics) and 
used as delivered. Anhydrous H3PO2 was prepared from aqueous 
H3PO2 solution (50% w/w) according to the procedure reported by 
Montchamp et al.31 N,O-Bis(trimethylsilyl)acetamide (BSA) was 
purchased from Alfa Aesar (LOT: J24T014). All solvents were extra-
dried grade or distillated prior used. Reactions requiring inert 
conditions were carried out in flame‐dried glassware under an argon 
atmosphere.  
NMR spectra were recorded at room temperature on a Bruker 
Avance‐III‐400 spectrometer (1H: 400 MHz, 13C: 101 MHz, 31P: 
162 MHz, 19F: 377 MHz). Chemical shifts () were given in ppm and 
coupling constants J in Hz. 1H NMR spectra were calibrated on non-
deuterated solvent residual peak (H2O: 4.79 ppm) while H3PO4 (85% 
in water) was used as an external standard for 31P NMR notably for 
the monitoring of the reaction. The following abbreviations were 
used for 1H, 13C, 31P and 19F NMR spectra to indicate the signal 
multiplicity: s (singlet), bs (broad singlet), d (doublet), dt (doublet of 
triplets), dm (doublet of mutiplets), t (triplet), td (triplet of doublets) 
and m (multiplet). All 13C NMR spectra were measured with 1H 
decoupling while 31P and 19F NMR spectra were measured with 1H 
coupling (zoom on the spectrum) and 1H decoupling. The reactions 
were followed by 31P and 31P{1H} NMR experiments (the spectra were 
recorded without lock and shims). 
High-resolution mass spectra (HRMS) were performed on a Bruker 
maXis mass spectrometer in negative (ESI-) mode by the "Fédération 
de Recherche" ICOA/CBM (FR2708) platform. MS analyses were 
performed using a Q-TOF Impact HD mass spectrometer equipped 
with the electrospray (ESI) ion source (Bruker Daltonics). The 
instrument was operated in the negative mode with an ESI source on 
a Q-TOF mass spectrometer with an accuracy tolerance of 2 ppm. 
Samples were diluted with acetonitrile and water (15:85) and were 
analysed by mass spectrometry in continuous infusion using a syringe 
pump at 200 µL/min. The mass profiles obtained by ESI-MS were 
analysed using DataAnalysis software (Bruker Daltonics). 
Infrared spectra were recorded on a ThermoFisher scientific Nicolet 
380 FT-IR Spectrometer. Smart OMNI-Sampler Germanium 
ATR Sampling Accessory was used. The Smart OMNI-Sampler 
used an extremely rugged germanium ATR crystal. The wave 
numbers were expressed in cm-1 and comprised between 4000 and 
675 cm-1. The samples were analysed neat. The following 
abbreviations were used for IR spectra to indicate the signal 
intensities: w (weak), m (medium), s (strong), br (broad). 
 
General procedure for method A. To a dry and argon flushed 100 mL 
three-necked flask equipped with a thermometer, an argon inlet and 
an addition funnel, were successively introduced anhydrous 
hypophosphorous acid (660 mg, 10.0 mmol) and anhydrous 
tetrahydrofuran (1 mL) under argon atmosphere. 
N,O-Bis(trimethylsilyl)acetamide (BSA) (3.055 g, 20.0 mmol) was 
added dropwise at 0 °C under argon and the mixture was stirred for 
40 minutes. The reaction conversion was monitored by 31P NMR 
spectroscopy. To another dry and argon flushed 100 mL three-
necked flask equipped with a thermometer, an argon inlet and an 
addition funnel, were successively introduced acid chloride (5.0 
mmol) and anhydrous tetrahydrofuran (2.25 mL). The 
bis(trimethylsilyl)phosphonite was added dropwise at -70 °C. The 
reaction was monitored by 31P NMR spectroscopy. The reaction 
mixture was quenched by methanol (10 mL) and the mixture was 
stirred for 25 minutes. Then, methanol was evaporated under 
reduced pressure following by a pH adjustment to 7.0 with an 
aqueous solution of sodium hydroxide (0.5 M) and the solution was 
lyophilised. The crude residue was washed with methanol (Na2HPO3 
removal) and ethanol (acetamide removal) to give a pure solid.  
 
Optimised experimental procedure for method B. To a dry and 
argon flushed 100 mL three-necked flask equipped with a 
thermometer, an argon inlet and an addition funnel, were 
successively introduced anhydrous hypophosphorous acid (660 mg, 
10.0 mmol) and anhydrous tetrahydrofuran (2 mL) under argon 
atmosphere. N,O-Bis(trimethylsilyl)acetamide (BSA) (3.055 g, 20.0 
mmol) was added dropwise at 0 °C under argon and the mixture was 
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stirred for 40 minutes. The reaction conversion was monitored by 31P 
NMR spectroscopy. A solution of acid chloride (5.0 mmol) in 
anhydrous tetrahydrofuran (1 mL) was added dropwise at 0 °C. The 
reaction was monitored by 31P NMR spectroscopy. The reaction 
mixture was quenched by methanol (10 mL) and the mixture was 
stirred for 25 minutes. Then, methanol was evaporated under 
reduced pressure following by a pH adjustment to 7.0 with an 
aqueous solution of sodium hydroxide (0.5 M) and the solution was 
lyophilised. The crude residue was washed with methanol (Na2HPO3 
removal) and ethanol (acetamide removal) to give a pure solid. 
1-Hydroxyethane-1,1-bis(H-phosphinate) disodium salt (6a). 
White powder (0.99 g, 4.55 mmol, 91% yield); IR (neat, cm-1) = 
3301br, 2375w, 1187s, 1072m, 962m, 742m; 31P{1H} NMR (162 MHz, 
D2O)  25.9 (s); 31P NMR (162 MHz, D2O)  25.9 (dm, 1JP-H = 524.8 Hz); 
1H NMR (400 MHz, D2O)  6.84 (dm, 1JP-H = 524.8 Hz, 2H), 1.31 (t, 3JP-
H = 15.3 Hz, 3H); 13C NMR (101 MHz, D2O)  71.4 (t, 1JP-C = 96.3 Hz), 
14.4. These data are in agreement with those previously reported.21 
1-Hydroxy-1-phenylmethane-1,1-bis(H-phosphinate) disodium 
salt (6b). White powder (1.22 g, 4.36 mmol, 87% yield); IR (neat, cm-
1) = 3263br, 2973w, 2317w, 1601w, 1489w, 1446w, 1395w, 1195s, 
1119m, 975m, 732m; 31P{1H} NMR (162 MHz, D2O)  24.4 (s); 
31P NMR (162 MHz, D2O)  24.4 (dm, 1JP-H = 538.2 Hz); 1H NMR (400 
MHz, D2O)  7.48 – 7.42 (m, 2H), 7.34 (t, 3J = 7.0 Hz, 2H), 7.26 – 7.16 
(m, 1H), 6.94 (dm, 1JP-H = 538.2 Hz, 2H); 13C NMR (101 MHz, D2O)  
136.1, 128.5 (2C), 127.2, 125.4 (2C), 77.4 (t, 1JP-C = 91.8 Hz). These 
data are in agreement with those previously reported.21 
1-Hydroxy-2-methylpropane-1,1-bis(H-phosphinate) disodium 
salt (6c). White powder (1.17 g, 4.76 mmol, 95% yield); IR (neat, cm-
1)  3361br, 2969w, 2371w, 1185s, 1106m, 974m, 755m; 31P{1H} 
NMR (162 MHz, D2O)  24.8 (s); 31P NMR (162 MHz, D2O)  24.8 (dm, 
1JP-H = 529.6 Hz); 1H NMR (400 MHz, D2O)  7.02 (dm, 1JP-H = 529.6 Hz, 
2H), 2.39 – 2.22 (m, 1H), 1.11 (d, 3J = 6.8 Hz, 6H); 13C NMR (101 MHz, 
D2O)  76.5 (t, 1JP-C = 92.8 Hz), 31.1, 17.4 (2C); MS (ESI-) m/z: 201.00 
[M-H]-, 222.99 [M-2H+Na]-, 183.00 [M-H-H2O]-, 135.02 [M-H-H3PO2]-
; HRMS (ESI-) m/z: [M-H]- Calcd. for [C4H11O5P2]: 201.0087, found: 
201.0088. 
1-Hydroxy-3-methylbutane-1,1-bis(H-phosphinate) disodium 
salt (6d). White powder (1.20 g, 4.63 mmol, 93% yield); IR (neat, cm-
1)  3215br, 2955w, 2314w, 1185s, 1107m, 1049w, 747w; 31P{1H} 
NMR (162 MHz, D2O)  25.1 (s); 31P NMR (162 MHz, D2O)  25.1 (dm, 
1JP-H = 526.0 Hz); 1H NMR (400 MHz, D2O)  6.91 (dm, 1JP-H = 526.0 Hz, 
2H), 2.17 – 2.03 (m, 1H), 1.70 (td, 3JP-H = 12.9 Hz, 3J = 6.0 Hz, 2H), 0.95 
(d, 3J = 6.5 Hz, 6H); 13C NMR (101 MHz, D2O)  75.2 (t, 1JP-C = 94.2 Hz), 
38.5, 24.2 (2C), 23.8 (t, 3JP-C = 7.7 Hz); MS (ESI-) m/z: 215.02 [M-H]-, 
237.01 [M-2H+Na]-, 197.01 [M-H-H2O]-, 149.04 [M-H-H3PO2]-; HRMS 
(ESI-) m/z: [M-H]- Calcd. for [C5H13O5P2]: 215.0244, found: 215.0243. 
1-Hydroxyhexane-1,1-bis(H-phosphinate) disodium salt (6e). 
White powder (1.17 g, 4.27 mmol, 86% yield); IR (neat, cm-1) = 
3328br, 2956w, 2303w, 1182s, 1105m, 959m, 746w; 31P{1H} NMR 
(162 MHz, D2O)  25.1 (s); 31P NMR (162 MHz, D2O)  25.1 (dm, 1JP-H 
= 525.6 Hz); 1H NMR (400 MHz, D2O)  6.92 (dm, 1JP-H = 525.6 Hz, 2H), 
1.87 – 1.69 (m, 2H), 1.61 –1.43 (m, 2H), 1.38 – 1.18 (m, 4H), 0.93 – 
0.75 (m, 3H); 13C NMR (101 MHz, D2O)  74.2 (t, 1JP-C = 94.9 Hz), 32.0, 
30.6, 22.2 (t, 3JP-C = 6.5 Hz), 21.8, 13.3; MS (ESI-) m/z: 229.04 [M-H]-, 
251.02 [M-2H+Na]-, 211.03 [M-H-H2O]-, 163.05 [M-H-H3PO2]-; HRMS 
(ESI-) m/z: [M-H]- Calcd. for [C6H15O5P2]: 229.0400, found: 229.0402.  
1-Hydroxy-2-phenylethane-1,1-bis(H-phosphinate) disodium 
salt (6f). White powder (1.24 g, 4.5 mmol, 90% yield); IR (neat, cm-1) 
= 3288br, 2987m, 2901m, 2314w, 1188s, 1122m, 1057m, 757m; 
31P{1H} NMR (162 MHz, D2O)  23.8 (s); 31P NMR (162 MHz, D2O)  
23.8 (dm, 1JP-H = 532.2 Hz); 1H NMR (400 MHz, D2O)  7.36 – 7.27 (m, 
2H), 7.26 – 7.12 (m, 3H), 6.71 (dm, 1JP-H = 532.2 Hz, 2H), 3.04 (t, 3J = 
12.4 Hz, 2H); 13C NMR (101 MHz, D2O)  135.3 (t, 3JP-C = 7.9 Hz), 131.2 
(2C), 128.0 (2C), 126.7, 73.6 (t, 1JP-C = 94.9 Hz), 35.3. These data are 
in agreement with those previously reported.21 
1-Hydroxy-1-(4-tolyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6g). White powder (1.39 g, 4.73 mmol, 95% yield); IR 
(neat, cm-1)  3236br, 2978w, 2900w, 2310w, 1647w, 1510w, 
1335w, 1188s, 1095s, 976m, 753m; 31P{1H} NMR (162 MHz, D2O)  
24.4 (s); 31P NMR (162 MHz, D2O)  24.4 (dm, 1JP-H = 537.0 Hz); 
1H NMR (400 MHz, D2O)  7.42 (dt, 3J = 8.1 Hz, 4JP-H = 1.7 Hz, 2H), 7.25 
(d, 3J = 8.1 Hz, 2H), 7.02 (dm, 1JP-H = 537.0 Hz, 2H), 2.31 (s, 3H); 13C 
NMR (101 MHz, D2O)  137.0 (t, 5JP-C = 2.6 Hz), 132.8, 128.8 (2C), 
125.3 (t, 3JP-C = 4.4 Hz, 2C), 77.0 (t, 1JP-C = 92.1 Hz), 20.1; MS (ESI-) m/z: 
249.01 [M-H]-, 270.99 [M-2H+Na]-, 231.00 [M-H-H2O]-, 183.02 [M-H-
H3PO2]-; HRMS (ESI-) m/z: [M-H]- Calcd. for [C8H11O5P2]: 249.0087, 
found: 249.0089. 
1-Hydroxy-1-(4-(tert-butyl)phenyl)methane-1,1-bis(H-
phosphinate) disodium salt (6h). White powder (1.73 g, 4.41 mmol, 
89% yield); IR (neat, cm-1)  3346br, 2988m, 2901m, 2322w, 
1662w, 1598w, 1509w, 1394w, 1182s, 1081s, 970w, 774m; 31P{1H} 
NMR (162 MHz, D2O)  24.5 (s); 31P NMR (162 MHz, D2O)  24.5 (dm, 
1JP-H = 537.7 Hz); 1H NMR (400 MHz, D2O)  7.53 – 7.45 (m, 4H), 7.01 
(dm, 1JP-H = 537.7 Hz, 2H), 1.27 (s, 9H); 13C NMR (101 MHz, D2O)  
150.4, 133.1, 125.3 – 125.2 (m, 4C), 77.1 (t, 1JP-C = 91.8 Hz), 33.8, 30.5 
(3C); MS (ESI-) m/z: 291.06 [M-H]-, 313.04 [M-2H+Na]-, 273.05 [M-H-
H2O]-, 225.07 [M-H-H3PO2]-; HRMS (ESI-) m/z: [M-H]- Calcd. for 
[C11H17O5P2]: 291.0557, found: 291.0557. 
1-Hydroxy-1-(4-methoxyphenyl)methane-1,1-bis(H-
phosphinate) disodium salt (6i). White powder (1.36 g, 4.38 mmol, 
88% yield); IR (neat, cm-1)  3247br, 3001w, 2902w, 2313w, 1609w, 
1509m, 1467w, 1191s, 1117m, 1034m, 975w, 740w; 31P{1H} NMR 
(162 MHz, D2O)  24.3 (s); 31P NMR (162 MHz, D2O)  24.3 (dm, 1JP-H = 
535.9 Hz); 1H NMR (400 MHz, D2O)  7.52 – 7.43 (m, 2H), 7.01 (dm, 
1JP-H  = 535.9 Hz, 2H), 7.01 (d, 3J  = 8.9 Hz, 2H), 3.81 (s, 3H); 13C NMR 
(101 MHz, D2O)  157.8, 128.4, 126.7 (t, 3JP-C = 4.5 Hz, 2C), 113.8 (2C), 
76.7 (t, 1JP-C = 92.9 Hz), 55.3; MS (ESI-) m/z: 265.00 [M-H]-, 286.99 [M-
2H+Na]-, 246.99 [M-H-H2O]-, 199.02 [M-H-H3PO2]-, 201.03 [M-H-
HPO2]-; HRMS (ESI-) m/z: [M-H]- Calcd. for [C8H11O6P2]: 265.0036 
found: 265.0036. 
1-Hydroxy-1-(4-fluorophenyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6j). White powder (1.26 g, 4.24 mmol, 85% yield); IR 
(neat, cm-1)  3224br, 2987m, 2309w, 1606w, 1507m, 1194s, 
1090s, 1056s, 975w, 748m; 31P{1H} NMR (162 MHz, D2O)  24.0 (d, 
6JP-F = 2.6 Hz); 31P NMR (162 MHz, D2O)  24.0 (dm, 1JP-H = 537.5 Hz); 
19F {1H} NMR (377 MHz, D2O)  -116.7 – -116.8 (m); 19F NMR (377 
MHz, D2O)  -116.6 – -116.8 (m); 1H NMR (400 MHz, D2O)  7.59 – 
7.50 (m, 2H), 7.20 – 7.12 (m, 2H), 7.04 (dm, 1JP-H = 537.5 Hz, 2H); 13C 
NMR (101 MHz, D2O)  161.9 (d, 1JC-F = 242.5 Hz), 131.8, 127.4 – 127.0 
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(m, 2C), 115.1 (d, 2JC-F = 21.5 Hz, 2C), 77.0 (t, 1JP-C = 91.6 Hz); MS (ESI-
) m/z: 252.98 [M-H]-, 274.97 [M-2H+Na]-, 234.97 [M-H-H2O]-, 187.00 
[M-H-H3PO2]-, 189.01 [M-H-HPO2]-; HRMS (ESI-) m/z: [M-H]- Calcd. 
for [C7H8FO5P2]: 252.9836, found: 252.9836. 
1-Hydroxy-1-(4-bromophenyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6k). White powder (1.19 g, 3.35 mmol, 67% yield); IR 
(neat, cm-1) = 3300br, 2309w, 3100w, 1581w, 1485w, 1195s, 
1119m, 975w, 760w; 31P{1H} NMR (162 MHz, D2O)  23.8 (s); 31P NMR 
(162 MHz, D2O)  23.8 (dm, 1JP-H = 539.5 Hz); 1H NMR (400 MHz, D2O) 
 7.58 (d, 3J = 7.1 Hz, 2H), 7.46 (d, 3J = 7.1 Hz, 2H), 7.02 (dm, 1JP-H = 
539.5 Hz, 2H); 13C NMR (101 MHz, D2O)  135.3, 131.2 (2C), 127.2 
(2C), 120.5, 77.1 (t, 1JP-C = 91.1 Hz); MS (ESI-) m/z: 312.90 [M-H]-, 
334.88 [M-2H+Na]-, 294.89 [M-H-H2O]-, 246.92 [M-H-H3PO2]-; HRMS 
(ESI-) m/z: [M-H]- Calcd. for [C7H8BrO5P2]: 312.9036, found: 
312.9036.  
1-Hydroxy-1-(4-trifluoromethoxyphenyl)methane-1,1-bis(H-
phosphinate) disodium salt (6l). White powder (1.35 g, 3.7 mmol, 
74% yield); IR (neat, cm-1)  3258br, 2989w, 2315w, 1610w, 1507w, 
1192s, 1118m, 1098m, 1056w, 975w, 742w; 31P{1H} NMR (162 MHz, 
D2O)  23.8 (s); 31P NMR (162 MHz, D2O)  23.8 (dm, 1JP-H = 539.3 Hz); 
19F {1H} NMR (377 MHz, D2O)  -57.8 (s).19F NMR (377 MHz, D2O)  -
57.8 (bs); 1H NMR (400 MHz, D2O)  7.59 (dm, 3J = 8.6 Hz, 2H), 7.33 
(d, 3J = 8.6 Hz, 2H), 7.03 (dm, 1JP-H = 539.3 Hz, 2H); 13C NMR (101 MHz, 
D2O)  147.9 (d, 3JC-F = 1.7 Hz), 135.0, 126.8 (t, 3JP-C = 4.3 Hz, 2C), 120.7 
(2C), 120.3 (q, 1JC-F = 256.1 Hz), 77.0 (t, 1JP-C = 90.9 Hz); MS (ESI-) m/z: 
318.96 [M-H]-, 337.95 [M-2H+Na]-, 300.96 [M-H-H2O]-, 255.00 [M-H-
H3PO2]-, 252.99 [M-H-HPO2]-; HRMS (ESI-) m/z: [M-H]- Calcd. for 
[C8H8F3O6P2]: 318.9754, found: 318.9753. 
1-Hydroxy-1-(4-(trifluoromethyl)phenyl)methane-1,1-bis(H-
phosphinate) disodium salt (6m). White powder (0.644 g, 1.85 
mmol, 37% yield); IR (neat, cm-1) = 3321br, 2320w, 1651w, 1611w, 
1193s, 1116, 1069s, 977w, 762m; 31P{1H} NMR (162 MHz, D2O)  23.6 
(s); 31P NMR (162 MHz, D2O)  23.6 (dm, 1JP-H = 540.4 Hz); 19F {1H} 
NMR (377 MHz, D2O)  -61.9 – -62.3 (m); 19F NMR (377 MHz, D2O)  
-61.9 – -62.3 (m); 1H NMR (400 MHz, D2O)  7.74 – 7.67 (m, 4H), 7.07 
(dm, 1JP-H  = 540.4 Hz, 2H); 13C NMR (101 MHz, D2O)  140.6, 128.3 
(dt, 2JC-F = 32.0 Hz, 5JP-C = 2.8 Hz), 125.8 – 125.7 (m, 2C), 125.2 – 125.0 
(m, 2C), 124.4 (q, 1JC-F = 271.0 Hz), 77.6 (t, 1JP-C = 90.0 Hz); MS (ESI-) 
m/z: 302.98 [M-H]-; HRMS (ESI-) m/z: [M-H]- Calcd. for [C8H8F3O5P2]: 
302.9799, found: 302.9798. 
1-Hydroxy-1-(3-tolyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6n).White powder (1.18 g, 4.00 mmol, 80% yield); IR 
(neat, cm-1) = 3414br, 2986w, 2900w, 2317w, 1602w, 1487w, 
1405w, 1119s, 1121m, 993w, 727w (P-C); 31P{1H} NMR (162 MHz, 
D2O)  24.5 (s); 31P NMR (162 MHz, D2O)  24.5 (dm, 1JP-H = 538.1 Hz); 
1H NMR (400 MHz, D2O)  7.41 (s, 1H), 7.39 – 7.30 (m, 2H), 7.19 (d, 3J 
= 6.3 Hz, 2H), 7.05 (dm, 1JP-H = 538.1 Hz, 2H), 2.36 (s, 3H); 13C NMR (101 
MHz, D2O)  138.3 (t, 4JP-C = 2.0 Hz), 136.0, 128.3, 127.6 (t, 4JP-C = 2.3 
Hz), 125.9 (t, 3JP-C = 4.4 Hz), 122.3 (t, 3JP-C = 4.4 Hz), 77.3 (t, 1JP-C = 91.7 
Hz), 20.8; MS (ESI-) m/z: 249.01 [M-H]-; HRMS (ESI-) m/z: [M-H]- 
Calcd. for [C8H11O5P2]: 249.0082, found: 249.0077. 
1-Hydroxy-1-(3-methoxyphenyl)methane-1,1-bis(H-
phosphinate) disodium salt (6o). White powder (1.25 g, 4.03 mmol, 
81% yield); IR (neat, cm-1) = 3399br, 2320w, 3001w, 2819w, 1601w, 
1580w, 1484w, 1432w, 1193s, 1120m, 1052m, 979w, 771w; 31P{1H} 
NMR (162 MHz, D2O)  24.3 (s); 31P NMR (162 MHz, D2O)  24.3 (dm, 
1JP-H = 539.3 Hz); 1H NMR (400 MHz, D2O)  7.36 (t, 3J = 8.2 Hz, 1H), 
7.20 – 7.14 (m, 2H), 7.05 (dm, 1JP-H = 539.3 Hz, 2H), 6.96 – 6.90 (m, 
1H), 3.85 (s, 3H); 13C NMR (101 MHz, D2O)  158.8, 138.1, 129.6, 
118.3 (t, 3JP-C = 4.0 Hz), 112.7, 111.2 (t, 3JP-C = 3.8 Hz), 77.5 (t, 1JP-C = 
93.3 Hz), 55.5; MS (ESI-) m/z: 265.00 [M-H]-, 286.99 [M-2H+Na]-, 
246.99 [M-H-H2O]-, 199.02 [M-H-H3PO2]-, 201.03 [M-H-HPO2]-; HRMS 
(ESI-) m/z: [M-H]- Calcd. for [C8H11O6P2]: 265.0036, found: 265.0037. 
1-Hydroxy-1-(3-fluorophenyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6p). White powder (1.04 g, 3.50 mmol, 70% yield); IR 
(neat, cm-1) = 3307br, 2988m, 2322w, 1738w, 1614w, 1587w, 
1481w, 1188m, 1076s, 1051s, 1012m, 740w; 31P{1H} NMR (162 MHz, 
D2O)  23.8 (s); 31P NMR (162 MHz, D2O)  23.8 (dm, 1JP-H = 540.2 Hz); 
19F {1H} NMR (377 MHz, D2O)  -113.3 (s); 19F NMR (377 MHz, D2O)  
-113.3 – -113.4 (m); 1H NMR (400 MHz, D2O)  7.46 – 7.37 (m, 1H), 
7.37 – 7.26 (m, 2H), 7.05 (dm, 1JP-H = 540.2 Hz, 2H), 7.11 – 7.00 (m, 
1H); 13C NMR (101 MHz, D2O)  162.6 (d, 1JC-F = 242.3 Hz), 138.8 (d, 
3JC-F = 7.6 Hz), 130.0 (d, 3JC-F =  8.4 Hz), 121.3 – 121.0 (m), 113.7 (dm, 
2JC-F = 21.3 Hz), 112.3 (dm, 2JC-F = 23.6 Hz),  77.1 (t, 1JP-C = 90.5 Hz); MS 
(ESI-) m/z: 252.98 [M-H]-, 274.97 [M-2H+Na]-, 234.97 [M-H-H2O]-, 
187.00 [M-H-H3PO2]-, 189.01 [M-H-HPO2]-; HRMS (ESI-) m/z: [M-H]- 
Calcd. for [C7H8FO5P2]: 252.9836, found: 252.9836. 
1-Hydroxy-1-(3-bromophenyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6q). White powder (1.11 g, 3.10 mmol, 62% yield); IR 
(neat, cm-1) = 3355br, 2979w, 2313w, 1590w, 1562w, 1473w, 
1195s, 1089m, 975w, 740w; 31P{1H} NMR (162 MHz, D2O)  23.7 (s); 
31P NMR (162 MHz, D2O)  23.7 (dm, 1JP-H = 540.4 Hz); 1H NMR 
(400 MHz, D2O)  7.79 – 7.67 (m, 1H), 7.60 – 7.45 (m, 2H), 7.30 (t, 3J 
= 7.8 Hz, 1H), 7.03 (dm, 1JP-H = 540.4 Hz, 2H); 13C NMR (101 MHz, D2O) 
 138.6, 130.0 (2C), 128.1, 124.1, 122.0, 77.0 (t, 1JP-C = 90.4 Hz); MS 
(ESI-) m/z: 312.90 [M-H]-, 334.89 [M-2H+Na]-, 296.89 [M-H-H2O]-, 
246.92 [M-H-H3PO2]-, 248.93 [M-H-HPO2]-; HRMS (ESI-) m/z: [M-H]- 
Calcd. for [C7H8BrO5P2]: 312.9036, found: 312.9037. 
1-Hydroxy-1-(2-tolyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6r). White powder (0.99 g, 3.35 mmol, 67% yield); IR 
(neat, cm-1) = 3217br, 2898m, 2901m, 2327w, 1452w, 1394w, 
1178m, 1080s, 975w, 753w; 31P{1H} NMR (162 MHz, D2O)  24.7 (s); 
31P NMR (162 MHz, D2O)  24.7 (dm, 1JP-H = 540.7 Hz); 1H NMR (400 
MHz, D2O)  7.65 – 7.58 (m, 1H), 7.28 – 7.14 (m, 3H), 7.12 (dm, 1JP-H 
= 540.7 Hz, 2H), 2.56 (s, 3H); 13C NMR (101 MHz, D2O)  137.7 – 137.3 
(m), 134.7, 132.7, 127.2, 126.9 (t, 3JP-C = 5.3 Hz), 125.4, 80.0 (t,  1JP-C = 
89.4 Hz), 22.2; MS (ESI-) m/z: 249.01 [M-H]-, 270.99 [M-2H+Na]-, 
231.00 [M-H-H2O]-, 183.02 [M-H-H3PO2]-; HRMS (ESI-) m/z: [M-H]- 
Calcd. for [C8H11O5P2]: 249.0087, found: 249.0087. 
1-Hydroxy-1-(2-methoxyphenyl)methane-1,1-bis(H-
phosphinate) disodium salt (6s). White powder (1.19 g, 3.85 mmol, 
77% yield); IR (neat, cm-1)  3676w, 2988w, 2900w, 2311w, 1580w, 
1489w, 1464w, 1206s, 1119m, 1057w, 967w, 757w; 31P{1H} NMR 
(162 MHz, D2O)  23.2 (s); 31P NMR (162 MHz, D2O)  23.2 (dm, 1JP-H 
= 552.7 Hz); 1H NMR (400 MHz, D2O)  7.47 (d, 3J = 6.3 Hz, 1H), 7.29 
(t, 3J = 7.2 Hz, 1H), 7.14 (dm, 1JP-H = 552.7 Hz, 2H), 7.11 – 6.94 (m, 2H), 
3.80 (s, 3H); 13C NMR (101 MHz, D2O)  156.4 (t, 3JP-C = 3.5 Hz), 128.3, 
126.6 (t, 3JP-C = 4.6 Hz), 125.5, 120.8, 111.5, 78.1 (t, 1JP-C = 88.6 Hz), 
55.1; MS (ESI-) m/z: 265.00 [M-H]-, 286.99 [M-2H+Na]-, 246.99 [M-H-
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H2O]-, 199.02 [M-H-H3PO2]-, 201.03 [M-H-HPO2]-; HRMS (ESI-) m/z: 
[M-H]- Calcd. for [C8H11O6P2]: 265.0036, found: 265.0037. 
1-Hydroxy-1-(2-fluorophenyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6t). White powder (1.00 g, 3.36 mmol, 67% yield); IR 
(neat, cm-1) = 3261br, 3036w, 2325w, 1614w, 1485w, 1447w, 
1194s, 1116m, 1089m, 968w, 753w; 31P{1H} NMR (162 MHz, D2O)  
22.0 (d, 4JP-F = 14.9 Hz); 31P NMR (162 MHz, D2O)  22.0 (dm, 1JP-H = 
549.6 Hz); 19F {1H} NMR (377 MHz, D2O)  -108.8 (t, 4JP-F = 15.0 Hz); 
19F NMR (377 MHz, D2O)  -108.7 – -109.0 (m); 1H NMR (400 MHz, 
D2O)  7.65 – 7.51 (m, 1H), 7.41 – 7.29 (m, 1H), 7.29 – 7.19 (m, 1H), 
7.17 (dm, 1JP-H = 549.6 Hz, 2H), 7.16 – 7.05 (m, 1H); 13C NMR (101 
MHz, D2O)  159.1 (dt, 1JC-F = 243.9 Hz, 3JP-C = 3.4 Hz), 129.2 – 129.0 
(m), 128.1 – 127.1 (m), 124.3, 123.7 (dm, 2JC-F = 14.7 Hz), 115.7 (d, 
2JC-F = 22.6 Hz), 77.4 (td, 1JP-C = 87.2 Hz, 3JC-F = 6.2 Hz).These data are 
in agreement with those previously reported.21 
1-Hydroxy-1-(2-bromophenyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6u). White powder (0.74 g, 2.30 mmol, 46% yield). IR 
(neat, cm-1) = 3397br, 2986w, 2316w, 1466w, 1302w, 1197s, 
1115m, 976w, 754w; 31P{1H} NMR (162 MHz, D2O)  21.4 (s); 31P NMR 
(162 MHz, D2O)  21.4 (dm, 1JP-H = 554.4 Hz); 1H NMR (400 MHz, D2O) 
 7.70 (d, 3J = 6.8 Hz, 1H), 7.63 (d, 3J = 7.7 Hz, 1H), 7.45 (dm, 1JP-H = 
554.4 Hz, 2H), 7.38 (t, 3J = 7.7 Hz, 1H), 7.18 (t, 3J = 7.4 Hz, 1H); 13C NMR 
(101 MHz, D2O)  137.3 – 137.0 (m), 134.4, 128.8 (t, 3JP-C = 4.3 Hz), 
128.6, 127.2, 120.0 (t, 3JP-C = 4.4 Hz), 79.0 (t, 1JP-C = 85.5 Hz); MS (ESI-
) m/z: 312.90 [M-H]-, 334.88 [M-2H+Na]-, 296.89 [M-H-H2O]-, 246.92 
[M-H-H3PO2]-, 248.93 [M-H-HPO2]-; HRMS (ESI-) m/z: [M-H]- Calcd. 
for [C7H8BrO5P2]: 312.9036, found: 312.9034. 
1-Hydroxy-1-napthylmethane-1,1-bis(H-phosphinate) 
disodium salt (6v). White powder (1.04 g, 3.12 mmol, 63% yield); IR 
(neat, cm-1) = 3311br, 2373w, 2994w, 1182s, 1095m, 966m, 784s; 
31P{1H} NMR (162 MHz, D2O)  24.6 (s); 31P NMR (162 MHz, D2O)  
24.6 (dm, 1JP-H = 544.5 Hz); 1H NMR (400 MHz, D2O)  8.90 – 8.81 (m, 
1H), 7.94 –7.83 (m, 3H), 7.59 – 7.49 (m, 3H), 7.29 (dm, 1JP-H = 544.5 
Hz, 2H); 13C NMR (101 MHz, D2O)  134.2, 133.7 – 133.5 (m), 131.3 – 
131.1 (m), 128.6, 128.0, 127.5, 125.7, 125.4, 125.2, 124.8 – 124.6 (m), 
80.2 (t, 1JP-C = 87.9 Hz); MS (ESI-) m/z: 285.01 [M-H]-, 306.99 
[M-2H+Na]-, 267.00 [M-H-H2O]-, 219.02 [M-H-H3PO2]-, 221.04 [M-H-
HPO2]-; HRMS (ESI-) m/z: [M-H]- Calcd. for [C11H11O5P2]: 285.0087, 
found: 285.0086. 
1-(Fur-2-yl)-1-hydroxymethane-1,1-bis(H-phosphinate) 
disodium salt (6w). White powder (0.74 g, 2.75 mmol, 55% yield); IR 
(neat, cm-1) = 3318br, 3104w, 2316w, 1651w, 1579w, 1486w, 
1301w, 1198s, 1122m, 989w, 725w; 31P{1H} NMR (162 MHz, D2O)  
21.4 (s); 31P NMR (162 MHz, D2O)  21.4 (dm, 1JP-H = 544.2 Hz); 
1H NMR (400 MHz, D2O)  7.52 (bs, 1H), 7.04 (dm, 1JP-H = 544.2 Hz, 
2H), 6.49 – 6.45 (m, 1H), 6.45 – 6.41 (m, 1H); 13C NMR (101 MHz, D2O) 
 149.0, 143.1, 110.6, 107.8 (t, 3JP-C = 4.9 Hz), 74.8 (t, 1JP-C = 91.8 Hz); 
MS (ESI-) m/z: 224.97 [M-H]-, 246.95 [M-2H+Na]-, 206.96 [M-H-H2O]-
, 158.99 [M-H-H3PO2]-, 161.00 [M-H-HPO2]-; HRMS (ESI-) m/z: [M-H]- 
Calcd. for [C5H7O6P2]: 224.9723, found: 224.9723. 
1-Hydroxy-1-(2-thienyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6x). White powder (1.00 g, 3.50 mmol, 70% yield); IR 
(neat, cm-1) = 3303br, 2962w, 2309w, 1665w, 1422w, 1433w, 
1368w, 1191s, 1096m, 971w, 724w; 31P{1H} NMR (162 MHz, D2O)  
23.0 (s); 31P NMR (162 MHz, D2O)  23.0 (dm, 1JP-H = 540.9 Hz); 
1H NMR (400 MHz, D2O  7.46 – 7.37 (m, 1H), 7.20 – 7.05 (m, 2H), 
7.02 (dt, 1JP-H = 540.9 Hz, 2H); 13C NMR (101 MHz, D2O)  139.8, 127.6, 
125.0, 123.5, 76.8 (t, 1JP-C = 91.4 Hz); MS (ESI-) m/z: 240.95 [M-H]-, 
262.93 [M-2H+Na]-, 222.94 [M-H-H2O]-, 174.96 [M-H-H3PO2]-, 176.98 
[M-H-HPO2]-; HRMS (ESI-) m/z: [M-H]- Calcd. for [C5H7O5P2S]: 
240.9495, found: 240.9496.  
1-Hydroxy-1-(3-azidopropyl)methane-1,1-bis(H-phosphinate) 
disodium salt (6y). White powder (1.13 g, 3.94 mmol, 80% yield); IR 
(neat, cm-1) = 3304br, 2962w, 2309w, 1665w, 1422w, 1433w, 
1368w, 1191s, 1096m, 971w, 724w; 31P{1H} NMR (162 MHz, D2O)  
24.6 (s); 31P NMR (162 MHz, D2O)  24.6 (dm, 1JP-H = 527.6 Hz); 
1H NMR (400 MHz, D2O)  6.85 (dm, 1JP-H = 527.6 Hz, 2H), 3.60 – 3.06 
(m, 2H), 1.85 – 1.67 (m, 4H); 13C NMR (101 MHz, D2O)  73.7 (t, 1JP-C 
= 94.3 Hz), 51.7, 27.6, 22.5 (t, 3JP-C = 6.6 Hz); MS (ESI-) m/z: 242.01 
[M-H]-; HRMS (ESI-) m/z: [M-H]- Calcd. for [C4H10N3O5P2]: 242.0101, 
found: 242.0103. 
1-Hydroxy-1-(3-aminopropyl)methane-1,1-bis(H-phosphinate) 
disodium salt (12). To a solution of 6y (59 mg, 0.21 mmol) in 
H2O/MeOH: 1/1 (4 mL) was added Pd/C (10%, 6 mg). The system was 
flushed with a dihydrogen balloon. The reaction mixture was stirred 
under dihydrogen atmosphere for 2 hours. The end of the reaction 
was monitored by 31P NMR spectroscopy. Then, the mixture was 
filtered over a pad of celite®. After solvent evaporations, the residue 
was dissolved in water (2 mL) and an aqueous solution of sodium 
hydroxide 1M was added until pH = 11. The solution was lyophilised. 
The crude product was purified by simple washes (ethanol and 
methanol) to give a white powder (43 mg, 0.16 mmol, 80% yield), 
31P{1H} NMR (162 MHz, D2O)  25.0 (s); 31P NMR (162 MHz, D2O)  
25.0 (dm, 1JP-H = 525.5 Hz); 1H NMR (400 MHz, D2O)  6.92 (dt, 1JP-H = 
525.9 Hz, 4J = 16.9 Hz, 2H), 2.60 (t, 3J =6.8 Hz, 2H), 1.91 – 1.75 (m, 2H), 
1.75 – 1.62 (m, 2H); 13C NMR (101 MHz, D2O)  73.8 (t, 1JP-C = 96.0 Hz), 
41.2, 28.0, 25.9 (t, 3JP-C = 6.7 Hz). These data are in agreement with 
those previously reported.20 
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